Navigation Links
Shengtai Pharmaceutical, Inc. Comments on China's Recently Approved Health Care Reform Plan
Date:2/5/2009

WEIFANG, China, Feb. 5 /PRNewswire-Asia-FirstCall/ -- Shengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) ("Shengtai" or "the Company"), a leading manufacturer and distributor of high-quality, pharmaceutical grade glucose products in China, today commented on a recently released State Council approved plan to spend a total of 850 billion RMB (USD 123 billion) by 2011 to provide universal primary medical services. Over the next three years, the multi-billion health care plan is aimed at expanding the government-sponsored medical insurance network to provide affordable, basic health care coverage to over 90% of the population. The plan seeks to expand health care services by targeting the country's approximately 900 million farmers, many of whom lack basic medical insurance, to ensure they are covered under the program. Under the plan, each person covered by the program will receive an annual health care subsidy after the 2010 year. In addition, the government will build hospitals and community health clinics to improve medical services in the rural and under-developed areas.

"We believe Shengtai stands to benefit from the government's plan as our pharmaceutical grade glucose is a basic raw material used in medical transfusions, which is also the most common form of medical treatment in China," said Mr. Qingtai Liu, Shengtai Pharmaceutical's CEO. "As the government builds more rural hospitals and community health clinics, we believe there will be an increased demand for glucose as more patients receive transfusions as part of their basic medical services. With our state-of-the-art glucose production facilities, we have the production capacity to meet the anticipated increase in glucose demand. This production expansion, in addition to the recent reorganization of our domestic and international sales department, positions us so we are ready to take advantage of additional market opportunities. Our actions are part
'/>"/>

SOURCE Shengtai Pharmaceutical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Shengtai Pharmaceutical, Inc. Reports Record 2007 Annual Results
2. Shengtai Pharmaceutical, Inc. Reports First Quarter Results of Fiscal Year 2008
3. Shengtai Pharmaceutical, Inc. to Present at Roth Capital Phoenix Conference
4. Shengtai Pharmaceutical, Inc. to Present at Roth Conference
5. Shengtai Pharmaceutical, Inc. Reports Strong Second Quarter Results of Fiscal Year 2008
6. Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Third Quarter Results of Fiscal Year 2008
7. Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008
8. Shengtai Pharmaceutical Expands International Sales Program
9. Shengtai Pharmaceutical to Present at Roth 21st Annual OC Growth Stock Conference
10. Meretek Diagnostics and Otsuka America Pharmaceutical, Inc. Announce Completion of Merger
11. BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... Technology Association of Georgia in collaboration with ... Social Savvy Awards this week at a special ceremony ... in Downtown Atlanta. The event celebrates Georgia’s best and ... honored with the 2014 TAG Social Savvy People’s Choice ... in 6 other award categories: , , ...
(Date:9/18/2014)... (HealthDay News) -- Teens and young adults who,ve been ... that provides them with greater responsibility and independence early ... "We found that having a mentor provides a ... lead author, Steve McDonald, an associate professor of sociology ... news release. In conducting the study, published ...
(Date:9/18/2014)... Research led by Paulo Rodriguez, PhD, an assistant ... Health New Orleans, Stanley S. Scott Cancer Center, has ... Chop plays in the body,s ability to fight cancer. ... the activity and accumulation of cells that suppress the ... Orleans research team showed that when they removed Chop, ...
(Date:9/18/2014)... The Spartan race is known as ... course lengths of 3+miles (Sprint), 8+miles, (Super) and 12+miles ... signature obstacles designed to help participants discover their inner ... a Spartan Race and the feeling of accomplishment that ... and accept people of all ages, backgrounds, and fitness ...
(Date:9/18/2014)... September 18, 2014 Activz ... to announce the release of Activz Coconut Water ... liquid of young, organic coconuts from Thailand. Activz Coconut ... Activz Whole-Food Nutrition revolutionary line of produce powders available ... options. The new Activz Coconut Water Powder will ...
Breaking Medicine News(10 mins):Health News:Winners Honored at 2014 TAG Social Savvy Awards 2Health News:Winners Honored at 2014 TAG Social Savvy Awards 3Health News: Mentors May Steer Young People Toward More Rewarding Careers 2Health News:LSU Health research discovers means to free immune system to destroy cancer 2Health News:A Marine Corps Combat Veteran Teams Up with Spartan Races to Ease the Pain and Speed Up Recovery of Spartan Race Warriors with Topricin Pain Relief and Healing Creams 2Health News:A Marine Corps Combat Veteran Teams Up with Spartan Races to Ease the Pain and Speed Up Recovery of Spartan Race Warriors with Topricin Pain Relief and Healing Creams 3Health News:A Marine Corps Combat Veteran Teams Up with Spartan Races to Ease the Pain and Speed Up Recovery of Spartan Race Warriors with Topricin Pain Relief and Healing Creams 4Health News:New Activz Organic Coconut Water Powder Announced at Natural Products Expo East 2Health News:New Activz Organic Coconut Water Powder Announced at Natural Products Expo East 3
... BRANFORD, Conn., Sept. 5 CuraGen Corporation,(Nasdaq: CRGN ... that Dr. Frank M. Armstrong, President and Chief,Executive Officer, ... Bear,Stearns 20th Annual Healthcare Conference on Tuesday, September 11, ... held at The Grand Hyatt,New York in New York ...
... Va., Sept. 5 Traditional Latin,American foods have a ... foods that have brought families together for generations are,being ... Oftentimes Latin foods are prepared with high-calorie ingredients ... to the American Diabetes,Association (ADA), eating foods high in ...
... the Canadian Institutes of Health Research (CIHR) unveiled a ... of research it has funded. CIHR will require its ... freely available online within six months of publication. ... is a defining feature of science, and is essential ...
... PHOENIX, Sept. 4 TriWest Healthcare Alliance is,offering an ... have lost a loved one in service to our ... unit commanders, TriWest is partnering,with noted author and nationally ... killed in the line of duty. Through a ...
... MINNEAPOLIS, Sept. 4 HEI, Inc. (Nasdaq: HEII,-- ... closed on the sale of,substantially all of the ... Inc., a wholly-owned subsidiary of Dutch based Smartrac ... substantially all the assets of the,RFID division, including ...
... Brings Over 20 Years Of Experience ... in Sales, Marketing And Operational Excellence, LENEXA, Kan., ... ) announced the appointment of Thomas Kelly,Mann as chief ... than 20 years with 3M,s healthcare information technology,division where ...
Cached Medicine News:Health News:CuraGen to Present at the Bear Stearns 20th Annual Healthcare Conference 2Health News:Top Tips to Enjoy Healthy Latin Food Without Losing the Taste (Recipe) 2Health News:Top Tips to Enjoy Healthy Latin Food Without Losing the Taste (Recipe) 3Health News:Open access to health research publications 2Health News:TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program 2Health News:HEI, Inc. Closes on Sale of RFID Division Assets 2Health News:Mediware Names Thomas K. Mann Chief Executive Officer 2
(Date:9/18/2014)... and LONDON , ... era for biopharmaceutical companies. Competition for innovation, increasing ... to keep up with the fast-changing environment are ... influence clinical trials, and clinical trial costs continue ... patient recruitment. Studies conducted by industry ...
(Date:9/18/2014)... , Sept. 18, 2014  ADM Tronics ... DeNovi , Ph.D. to its corporate Advisory Board ... an instructor at the Harvard Medical School and ... Rome.  He received his Masters degree in Electronics ... Systems from the University of Bologna. After spending a ...
(Date:9/18/2014)... , Sept. 18, 2014 MiMedx Group, ... developer, processor and marketer of patent protected regenerative ... announced today that it has entered into a ... MiMedx will provide its dehydrated human amnion/chorion membrane ... non- exclusively on a private label basis. ...
Breaking Medicine Technology:Patient Recruitment in Asia Biotech and Pharma Companies 2Patient Recruitment in Asia Biotech and Pharma Companies 3ADM Tronics Appoints Gianluca DeNovi, Ph.D. To Advisory Board 2ADM Tronics Appoints Gianluca DeNovi, Ph.D. To Advisory Board 3MiMedx Signs Distribution Agreement With Zimmer 2MiMedx Signs Distribution Agreement With Zimmer 3
... and secondary endpoints of,study; no negative drug-drug ... CAMBRIDGE, Mass., June 12, 2007 /PRNewswire-FirstCall/ -- ... phase II study,designed to evaluate triple combination ... candidate for the,treatment of hepatitis C, pegylated ...
... II Study Demonstrates Significant,Additional Improvement for Patients ... /PRNewswire-FirstCall/ --,Indevus Pharmaceuticals, Inc. today announced that ... for pagoclone in persistent,developmental stuttering will be ... the New Clinical Drug Evaluation Unit (NCDEU), ...
Cached Medicine Technology:Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 2Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 3Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 4Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 5Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 6Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 2Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 3Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 4Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 5Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 6Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 7Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 8Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 9
Resorbable fixation system 1.5/2.0....
... Sonomed-315 is intended for visualization of the ... midline shifts in the brain, evaluation of ... to use, the Sonomed-315 offers quick and ... allows to identify the anatomic structures of ...
... cost, low volume alternative. Whole blood is drawn ... from whole blood by centrifugation in a standard ... Cebus single use cartridge. The cartridge is then ... the concentrating process. Finally, the cartridge is spun ...
Exclusive oxidized regenerated cellulose technology. The only oxidized regenerated cellulose hemostat line, surgicel absorbable hemostat delivers a unique combination of effectiveness, absorbability,...
Medicine Products: